Why is "Ethinylestradiol/drospirenone" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-09-02 02:13:38
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Ethinylestradiol/drospirenone entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-09-02 and was most recently seen on 2026-09-02.
Wikipedia Overview
Ethinylestradiol/drospirenone (EE/DRSP), sold under the brand name Yasmin among others, is a combination of ethinylestradiol (EE), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used as a birth control pill to prevent pregnancy in women. It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women. The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per tablet (brand names Yaz, Yasminelle, Nikki, others). A formulation with levomefolic acid (vitamin B9) has also been marketed (brand names Beyaz, Safyral, others), with similar indications. EE/DRSP is marketed widely throughout the world.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Case Report: Menstrual cycle–related psychosis in bipolar I disorder, remitting with a combined oral contraceptive - Frontiers
-
receives FDA approval for generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg - Lupin | Press Release - lupin.com
-
Ethinylestradiol/drospirenone - Springer Nature Link
-
A Highly Selective Method for the Analysis of Drospirenone in Human Plasma - LCGC International
-
Birth control pill brands: A comparison and how to get them - Medical News Today
-
Drospirenone and Ethinyl Estradiol birth control pills recalled over packaging error - ABC11 News
-
Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) due to out of specification (OOS) re - PR Newswire
-
Ischemic Stroke in Users of Combined Hormonal Contraceptives: A Danish Registry Study - ahajournals.org
-
The hormonal profile in women using combined monophasic oral contraceptive pills varies across the pill cycle: a temporal analysis of serum endogenous and exogenous hormones using liquid chromatography with tandem mass spectroscopy - American Physiological Society Journal
-
Mylan Launches Generic For Oral Contraceptive Yaz - drugdiscoverytrends.com
-
Update on Current Contraceptive Options - Cleveland Clinic
-
Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results - BioSpace
-
Anti-Androgen therapy may increase UTI risk in women - Urology Times
-
Birth control medication recalled over incorrect packaging - KVUE
-
Birth control tablet packs recalled due to incorrect arrangement - WMAR 2 News Baltimore
-
FDA recalls birth control due to packaging issue - WBMA
-
Drospirenone: less safe than other hormonal contraceptives? - Springer Nature Link
-
Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 blister pack/carton due to possibility of missing/incorrect tablet arrangement - PR Newswire
-
These 2 Types Of Birth Control Pills Are Being Recalled, So Here's What You Need To Know - elitedaily.com
-
Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis - Royal Australian College of General Practitioners (RACGP)
-
Camber Pharma Launches Generic YAZ® Tablets - Pharmacy Times
-
Why The Pill May Impair Sleep - Medical Professionals Reference
-
Hypertension in women - Hypertension Research - Nature
-
Oral Contraceptive Recalled Due to Possibility of Reduced Efficacy - Medical Professionals Reference
-
Birth control recalled over incorrect packaging - WQAD
-
Birth control pills recalled due to packaging error that could result in unintended pregnancy - ABC7 Los Angeles
-
Teva changes generic Yaz contraceptive label - Generics and Biosimilars Initiative
-
Multiple Drug Interaction in Patient Taking Antipsychotic, Other Routine Meds - Medical Professionals Reference
-
Kansas City pharmacist urges patients to check birth control after nationwide recall - kshb.com
-
FDA wants blood clot risks added to Yaz labels - CBS News
-
FDA Updates Warnings for Combined Hormonal Contraceptives - Managed Healthcare Executive
-
Sixty years of the combined oral contraceptive pill - The Pharmaceutical Journal
-
Apotex recalls tablets in US due to packaging error - packaging-gateway.com
-
Packaging error prompts nationwide recall of birth control pills - WDRB
-
Birth Control Pills Recalled Nationwide Due To Packaging Error - Patch
-
Camber launches generic Yaz - Drug Store News
-
Reblozyl: Uses, cost, how it works, dosage, and more - Medical News Today
-
Yaz Lawsuits - Drugwatch.com
-
Teva releases Rajani birth control pill - Chain Drug Review
-
Women Calling NYPD Stop-and-Frisk Tactics Sexual Intimidation - Patch
-
FDA Advisory No.2024-1321|| Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products: - Food and Drug Administration - fda.gov.ph
-
Introducing women to SA's new generic combination oral contraceptive - bizcommunity.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.